Dimethylbenz[α]anthracene induces oxidative stress and reduces the binding capacity of the mitochondrial 18-kDa translocator protein in rat aorta

Drug and Chemical Toxicology

Volumn 33, Issue 4, 2010, Pages 337-347

  Dimitrova Shumkovska, Jasmina ^a   Veenman, Leo ^b   Ristoski, Trpe ^a   Leschiner, Svetlana ^b   Gavish, Moshe ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

18 kDa translocator protein (TSPO); 7,12 dimethylbenz a anthracene (DMBA); Aorta; Endothelial inflammation; Oxidative stress; Polycyclic aromatic hydrocarbons (PAHs)

Indexed keywords

CARRIER PROTEIN; DIMETHYLBENZ[A]ANTHRACENE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; AORTA; CARRIER PROTEINS; LIGANDS; LIPID PEROXIDATION; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, GABA-A; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

RATTUS;

EID: 77956151015     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480540903483441     Document Type: Article

References (71)

1. Albert, R., Vanderlaan, M., Burns, F., Nishizumi, M. (1977). Efect of carcinogens on chicken atherosclerosis. Cancer Res 37:2232-2235.
2. 3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species diferences and heterogeneity in peripheral benzodiazepine binding sites. J Neurochem 495:1407-1414.
3. Baker, D. G., Taylor, H. W., Lee, S. P., Barker, S. A., Goad, M. E. P., Means, J. C. (2001). Hepatic toxicity and recovery of Fischer 344 rats following exposure to 2-aminoanthracene by intra-peritoneal injection. Toxicol Pathol 29:328-332.
4. Barros, A. C. S. D., Muranaka, E. N. K., Jo Mori, L., Pelinzon, C. H. T., Giocondo, G., Pinotti, J. A. (2004). Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz [a] anthracene. Rev Hosp Clin Fac Med S Paulo 59:257-261.
5. Batastini, G., Penn, A. (1984). An ultrastructural comparison of carcinogen-associated and spontaneous aortic lesions in the cockerel. Am J Pathol 114:403-409.
6. Canat, X., Carayon, P., Bouaboula, M., Cahard, D., Shire, D., Roque, C., et al. (1993). Distribution profle and properties of peripheral-type benzodiazepine receptors on human hemo-poietic cells. Life Sci 52:107-118.
7. Carter, J. H., Carter, H. W. (1988). Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: histopathology of mammary tumors. Cancer Res 48:3808-3815.
8. Catanzaro, D. F., Zhou, Y., Chen, R., Yu, F., Catanzaro, S. E., De Lorenzo, M. S., et al. (2007). Potentially reduced exposure cigarettes accelerate atherosclerosis: evidence for the role of nicotine. Cardiovasc Toxicol 7:192-201.
9. Costopoulos, C., Liew, T. V., Bennet, M. (2008). Ageing and atherosclerosis: mechanisms and therapeutic options. Biochem Pharamcol 75:1251-1261.
10. Curfs, D. M., Beckers, L., Godschalk, R. W., Gijbels, M. J., VanSchooten, F. J. (2003). Modulation of plasma lipid level afects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models. Environ Mol Mutagen 42:243-249.
11. Curfs, D. M. J., Lutgens, E., Gijbels, M. M. J., Kockx, M. M., Daemen, M. J. A. P., van Schooten, F. J. (2004). Chronic exposure to the carcinogenic compound benzo[α]pyrene induces larger and phenoltypically diferent atherosclerotic plaques in ApoE-knockout mice. Am J Pathol 164:101-108.
12. Curfs, D. M. J., Knaapen, A. M., Pachen, D. M. F. A., Gijbels, M. M. J., Lutgens, E., Smook, M. L. F., et al. (2005). Polycyclic aromatic hydrocarbons induce an infammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J 19:1290-1292
13. Danovich, l., Veenman, L., Leschiner, S., Lahav, M., Shuster, V., Weizman, A., et al. (2008). Te infuence of clozapine treatment and other antipsychotics on the 18-kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production. Eur Neuropsychopharmacol 18:24-33.
14. Delavoie, F., Li, H., Hardwick, M., Robert, J., Giatzakis, C., Peranzi, G., et al. (2003). In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional signif-cance in drug ligand and cholesterol binding. Biochemistry 42:4506-4519.
15. Demerle-Pallardy, C., Duverger, D., Spinnewyn, B., Pirotzky, E., Braquet, P. (1991). Peripheral-type benzodiazepine binding sites following transient forebrain ischemia in the rat: efect of neuroprotective drugs. Brain Res 565:312-320.
16. Draper, H. H., Hadley, M. (1990). Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 186:421-431.
17. 3H] Ro5-4864 binding to peripheral benzodiazepine receptors in rat heart and kidney. Pharmacol Biochem Behav 30:1015-1020.
18. Esterbauer, H., Chessman, K. H. (1990). Determination of alde-hydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407-421.
19. French, J. F., Matlib, M. A. (1988). Identifcation of a high-afnity peripheral-type benzodiazepine-binding site in rat aortic smooth muscle membranes. J Pharmacol Exp Ter 247:23-28.
20. Gairola, C. G., Drawdy, M. L., Block, A. E., Daugherty, A. (2001). Sidetream cigarette smoke accelerates atherogenesis in ApoE-/-mice. Atherosclerosis 1:49-55.
21. Gao, J., Lauer, F. T., Mitchell, L. A., Burchiel, S. W. (2007). Microsomal epoxide hydrolase is required for 7,12-dimethylbenz[a]anthracene DMBA-induced immunotoxic-ity in mice. Toxicol Sci 98:137-144.
22. Gavish, M., Bar-Ami, S., Weizman, R. (1992). Te endocrine system and mitochondrial benzodiazepine receptors. Mol Cell Endocrinol 88:1-13.
23. Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., et al. (1999). Enigma of the peripheral benzo-diazepine receptor. Pharmacol Rev 51:630-646.
24. Hakkak, R., Holley, A. W., Macleod, S. L., Simpson, P. M., Fuchs, G. J., Jo, C. H., et al. (2005). Obesity promotes 7,12-dimethylbenzaanthracene-induced mammary tumor development in female Zucker rats. Breast Cancer Res 5:R627-R633.
25. Harrigan, J. A., Vezina, C. M., McGarrigle, B. P., Ersing, N., Box, H. C., Maccubbin, A. E., et al. (2004). DNA adduct formation in precision-cut rat liver and lung slices exposed to benzoapyrene. Toxicol Sci 77:307-314.
26. Harrison, H. H., Levit, M. H. (1987). Serum protein electrophoresis: basic principles, interpretations, practical consideration. ASCI. Check sample. Core chemistry no. PTS 87-97 (PTS-25). ASCP. In:Wallach, J. (Ed.), Interpretation of diagnostic tests (pp 77-81). Chicago, Illinois, USA: Wolters Kluwer, Lippincot Williams & Wilkins, 2007.
27. Huberman, E., Chou, M. W., Yang, S. K. (1979). Identifcation of 7,12-dimethylbenz[α]antracene metabolites that lead to mutagenesis in mammalian cells. Proc Natl Acad Sci\USA 76:862-866.
28. Huggins, C., Grand, L., Fukunishi, R. (1964). Aromatic infuences on the yields of mammary cancers following administration of 7,12- dimethylbenzanthracene. Pathology 51:737-742.
29. Iwano, S., Shibahara, N., Saito, T., Kamataki, T. (2006). Activation of p53 as a causal step for atherosclerosis induced by polycy-clic aromatic hydrocarbons. FEBS Lett 580:890-893.
30. Izzotti, A., Balansky, R.M., Dagostini, F., Bennicelli, C., Myers, S.R., Grubbs, C.J., Lubet, R.A., Kellof, G.J., De Flora, S. (2001). Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res 61:2472-2479.
31. Krueger, K. E., Papadopoulos, V. (1990). Peripheral-type bezodi-zaepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem 265:15015-15022.
32. Kugler, W., Veenman, L., Shandalov, Y., Leschiner, S., Spanier, I., Lakomek, M., et al. (2008). Ligands of the mitochondrial 18-kDa translocator protein attenuate apoptosis in human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 30:435-450.
33. Kunduzova, O. R., Escourrou, G., De La Farge, F., Salvayre, R., Seguelas, M. H., Leducq, N., et al. (2004). Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol 15:2152-2160.
34. Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent,I., Lenz, A. G., et al. (1990). Determination of carbonyl content in oxidatively modifed proteins. Meth Enzymol 186:464-478.
35. Limón-Pacheco, J., Gonsebatt, M. E. (2009). Te role of antioxi-dant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 674:137-147.
36. Löscher, W. (2001). Do cocarcinogenic efects of ELF electromagnetic feld require repeated long-term interaction with carcinogens? Characteristics of positive studies using the DMBA breast cancer model in rats. Bioelectromagnetics 22:603-614.
37. Löscher, W., Mevissen, M., Lehmacher, W., Stamm, A. (1993). Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic feld. Cancer Lett 71:75-81.
38. Lowry, O. H., Rosenbrough, A. L., Randall, R. J. (1951). Protein measurement with Folin's phenol reagent. J.Biol Chem 193:265-275.
39. Maeda, S, Miyawaki, T., Nakanishi, T., Takigawa, M., Shimada, M. (1998). Peripheral-type benzodiazepine receptor in T-lymphocyte-rich preparation. Life Sci 63:1423-1430.
40. Majesky, M. W., Reidy, M. A., Benditt, E. P., Juchau, M. R. (1985). Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci 82:3450-3454.
41. Mefert, G., Gellerich, F. N., Margreiter, R., Wyss, M. (2005). Elevated creatine kinase activity in primary hepatocellular carcinoma. BMC Gastroeneterol 5:9.
42. Meisinger, C., Koenig, W., Baumert, J., Döring, A. (2008). Uric acid levels are associated with all-cause and coronary artery disease mortality independent of systemic infammation in men from general population. Te MONICA/KORA Kohort study. Arterioscler Tromb Vasc Biol 28:1186-1192.
43. Mevissen, M., Lerchl, A., Löscher, W. (1996). Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50-Hz magnetic feld. J Toxicol Environ Health 48:101-117.
44. Moorthy, B., Miller, K. P., Jiang, W., Ramos, K. S. (2002). Te atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cyto-chrome P4501B1. Cardiovasc Res 53:1002-1009.
45. Motoyama, J., Yamashita, N., Morina, T., Tanaka, M., Kobayashi, T., Honda, H. (2008). Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn Res Technol 6:2.
46. 3H] PK11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci Lett 133:20-24.
47. Netto, L. E., Kowaltowsky, A. J., Castilho, R. F., Vercesi, A. E. (2002). Tiol enzymes protecting mitochondria against oxidative damage. Meth Enzymol 348:260-270.
48. National Toxicology Program. (2006). NTP technical report on the toxicology and carcinogenesis studies of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin TCDD Cas.No1746-01-06 in female Harlan-Sprague-Dawley rats gavage studies. Natl Toxicol Prog Tech Rep Ser 521:4-232.
49. O'Beirne, G. B., Woods, M. J., Williams, D. C. (1990). Two subcel-lular locations for peripheral-type benzodizepine receptors in rat liver. Eur J Biochem 188:131-138.
50. Ohkawa, H., Ohishi, N., Yagi, K. (1978). Assay for lipid peroxida-tion in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
51. Oliveira, C. P., Coelho, A. M., Barbeiro, H. V., Lima, V. M., Soriano, F., Ribeiro, C., et al. (2006). Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 39:189-194.
52. Paigen, B., Holmes, P. A., Morrow, A., Mitchell, D. (1986). Efect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with diferent susceptibilites to methylcholan-threne-induced tumors. Cancer Res 46: 3321-3324.
53. Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., et al. (1997). Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62:21-28.
54. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J. J., Lindemann, P., et al. (2007). Translocator protein (18-kDa). New nomenclature for the peripheral-type-benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402-409.
55. Raa, A., Stansberg, C., Steen, V. M., Bjerkvig, R., Reed, R. K., Stuhr, L. E. B. (2007). Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors. BMC Cancer 7:23.
56. Revis, N. W., Bull, R., Laurie, D., Schiller, C. A. (1984). Te efec-tiveness of chemical carcinogens to induce atheroslcerosis in the white Carneau pigeon. Toxicology 32:215-227.
57. Ross, R. (1999). Atherosclerosis\an infammatory disease. NEJM 340:115-126.
58. Salvetti, F., Chelli, B., Gesi, M., Pellegrini, A., Giannaccini, G., Lucacchini, A., et al. (2000). Efect of noise exposure on rat cardiac peripheral benzodiazepine receptors. Life Sci 66:1165-1175.
59. Stoebner, P. E., Carayon, P., Penarier, G., Frechin, N., Barneon, G., Casellas, P., et al. (1999). Te expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell diferentiation. Br J Dermatol 140:1010-1016.
60. Szeto, H. H. (2006). Cell permeable, mitochondrial-targeted, pep-tide antioxidants. AAPS J 8:E277-E283.
61. 3H] diazepam binding to rat peritoneal mast cells. Life Sci 27:171-178.
62. Veenman, L., Gavish, M. (2006). Te peripheral-type benzodi-azepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ter 110:503-524.
63. Veenman, L., Leschiner, S., Spanier, I., Weisinger, G., Weizman, A., Gavish, M. (2002). PK11195 attenuates kainicacid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 80:917-927.
64. Veenman, L., Papadopoulos, V., Gavish, M. (2007). Channel-like functions of the 18-kDa translocator protein TSPO regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13:2385-2405.
65. Veenman, L., Shandalov, Y., Gavish, M. (2008). VDAC activation by the 18-kDa translocator protein (TSPO): implications for apoptosis. J Bioenerg Biomembr 40:199-205.
66. Veenman, L, Weizman, A., Weisinger, G., Gavish, M. (2009; In press). Expression and functions of the 18-kDa mitochon-drial translocator protein, TSPO, in health and disease. Targ Drug Deliv Cancer Ter
67. Wakabayashi, K. (1990). International commision for protection against environmental mutagens and carcinogens. ICPEMC working paper 7/1/3. Animal studies suggesting involvement of mutagen carciongen exposure in atherosclerosis. Mutat Res 239:181-187.
68. Whitsett, T., Carpenter, M., Lamartiniere, C. A. (2006). Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 5:15.
69. Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraf, J., et al. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1305.
70. Yousef, M. I., Awad, T. I., Mohamed, E. H. (2006). Deltamethrin-induced oxidative damage and biochemical alterations in rat and its attenuation by vitamin E. Toxicology 227:240-247.
71. Zeno, S., Zaaroor, M., Leschiner, S., Veenman, L., Gavish, M. (2009). CoCl(2) induces apoptosis via the 18-kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48:4652-4661.